Long‐term survival of head and neck squamous cell carcinoma after bone marrow transplant

Head & Neck ◽  
2020 ◽  
Vol 42 (11) ◽  
pp. 3389-3395
Author(s):  
Catriona M. Douglas ◽  
Ashock R. Jethwa ◽  
Wael Hasan ◽  
Amy Liu ◽  
Ralph Gilbert ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Bone Marrow Transplant ◽  
Squamous Cell ◽  
Marrow Transplant ◽  
Neck Squamous Cell Carcinoma ◽  
Term Survival

scholarly journals A clinical study of stage IV head and neck squamous cell carcinoma. Prognostic factors for long-term survival.

1998 ◽  
Vol 24 (1) ◽  
pp. 90-96
Author(s):  
Madoka FURUKAWA ◽  
Akira KUBOTA ◽  
Yuuji TANIGAKI ◽  
Kousuke YAMASITA ◽  
Masato SUGIYAMA ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factors ◽  
Clinical Study ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Stage Iv ◽  
Neck Squamous Cell Carcinoma ◽  
Term Survival

scholarly journals Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma

BMC Cancer ◽  
2009 ◽  
Vol 9 (1) ◽  
Author(s):  
Stuart C Winter ◽  
Sally-Anne Stephenson ◽  
Selva K Subramaniam ◽  
Vinidh Paleri ◽  
Kien Ha ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Tumour Cells ◽  
Neck Squamous Cell Carcinoma ◽  
Circulating Tumour Cells ◽  
Term Survival ◽  
Long Term Survival

Long-term efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck squamous cell carcinoma

2019 ◽  
Vol 46 (6) ◽  
pp. 882-888
Author(s):  
Hiroshi Okuda ◽  
Masami Ohnishi ◽  
Hiroki Takahashi ◽  
Chiaki Takagi ◽  
Natsuki Takada ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Concurrent Chemoradiotherapy ◽  
Neck Squamous Cell Carcinoma ◽  
Term Efficacy

Long-term toxicity following radiation therapy for head and neck squamous cell carcinoma: A retrospective study analyzing the effect of concurrent chemotherapy and advanced t-stage on late treatment-induced toxicities.

2019 ◽  
Vol 37 (15_suppl) ◽  
pp. e17560-e17560
Author(s):  
William Barrett ◽  
Christine Cassidy
Keyword(s):  
Squamous Cell Carcinoma ◽  
Radiation Therapy ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Late Effects ◽  
Neck Squamous Cell Carcinoma ◽  
Definitive Chemoradiation

e17560 Background: There are approximately 436,000 survivors of head and neck squamous cell carcinoma (HNSCC) in the U.S. Toxicities related to definitive chemoradiation or radiation therapy can persist for many years, with some toxicities not presenting clinically until five or more years after definitive treatment. Long-term management of late radiotherapy effects is thus warranted. Methods: This retrospective chart review has three aims: (1) comprehensively assess overall late effects of definitive radiation and chemoradiation; (2) compare treatment-related toxicities between definitive radiation and chemoradiation; and (3) compare treatment-related toxicities between patients with TNM stage T1/T2 tumors to T3/T4 tumors. Late term effects were assessed using 17 toxicity categories including xerostomia, dysphagia, and neck fibrosis. HNSCC patients included in the study were those seen by a single practitioner for follow-up of definitive radiation or chemoradiation, without a history of surgical intervention to the primary site, between June 2017 and June 2018 (N = 49). Results: The median time from the end of treatment to the most recent follow-up was 8.53 years (1.17-24.08 years). In the total cohort, the most common late effect was xerostomia (78%, N = 38), followed by dysphagia (43%, N = 21), and neck fibrosis (27%, N = 13). For the majority of toxicity categories (11 of 17), the cohort that received definitive chemoradiation had higher rates of toxicity than the cohort that received definitive radiation alone. Additionally, for the majority of toxicity categories (10 of 17), the cohort of T3/T4 tumors had higher rates of long-term toxicity than the cohort of T1/T2 tumors. Conclusions: Although the patient population in this study has excellent locoregional control after definitive radiation or chemoradiation, the majority of patients suffer from long-term treatment-related toxicities. Long-term follow up care is needed to manage the late effects of radiotherapy that can develop and persist for years after treatment completion.

scholarly journals Chemotherapy-Induced Skin Changes Masquerading as Squamous Cell Carcinoma In Situ in a Post-Bone Marrow Transplant Patient

2012 ◽  
Vol 138 (suppl 2) ◽  
pp. A026-A026 ◽  
Author(s):  
Julie A. Rosser ◽  
Ranjana Arora ◽  
Roshan Patel ◽  
Michael L. Cibull ◽  
Dianna S. Howard ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Bone Marrow Transplant ◽  
Squamous Cell ◽  
Carcinoma In Situ ◽  
Transplant Patient ◽  
Marrow Transplant ◽  
Skin Changes
Sign in / Sign up

Export Citation Format

Share Document